Michael S. Singer

Also affiliated with Cara Therapeutics (United States)

Agricultural and Biological SciencesEnvironmental Science

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 1 paper. Top paper: “Safety and clinical activity of autologous RNA chimeric antigen receptor T-cell therapy in myasthenia gravis (MG-001): a prospective, multicentre, open-label, non-randomised phase 1b/2a study”.

Safety and clinical activity of autologous RNA chimeric antigen receptor T-cell therapy in myasthenia gravis (MG-001): a prospective, multicentre, open-label, non-randomised phase 1b/2a study

The Lancet Neurology(2023)10.1016/s1474-4422(23)00194-1

N/A

5.4DataRank · unranked

260 citations

Michael Benatar, Metin Kurtoğlu, Miloš D. Miljković, Nizar Chahin, Gregory Sahagian +37 more